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The asymmetric unit of the crystal contains one-fourth of the
title compound, C10H22N2O2, with the centre of the piperazine
ring located at a site of 2/m symmetry. The piperazine ring
adopts a chair conformation. The methine and methylene C
atoms of the 2-hydroxypropyl groups show symmetry-imposed
disorder over two equally occupied and mutually exclusive
sets of positions. Only intramolecular O—H   N contacts are
observed.
Related literature
For the biological properties of piperazine compounds, see:
Foroumadi et al. (2007); Upadhayaya et al. (2004); Chen et al.
(2006); Cunico et al. (2009); Smits et al. (2008); Penjis ˇevic ´ et al.
(2007); Becker et al. (2006). For hydrogen-bond graph-set
motifs, see: Bernstein et al. (1995). For ring puckering para-






a = 13.838 (10) A ˚
b = 7.791 (5) A ˚
c = 5.543 (4) A ˚
  = 97.26 (3) 
V = 592.8 (7) A ˚ 3
Z =2
Mo K  radiation
  = 0.08 mm
 1
T = 273 K



















 max = 0.28 e A ˚  3
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Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
O1—H1   N1 0.82 2.22 2.696 (3) 117
Data collection: PROCESS-AUTO (Rigaku, 1998); cell reﬁne-
ment: PROCESS-AUTO; data reduction: CrystalStructure (Rigaku/
MSC, 2004); program(s) used to solve structure: SHELXS97 (Shel-
drick, 2008); program(s) used to reﬁne structure: SHELXL97
(Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows
(Farrugia, 1997); software used to prepare material for publication:
WinGX (Farrugia, 1999) and PLATON (Spek, 2009).
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1,1'-(Piperazine-1,4-diyl)dipropan-2-ol
M. Türkyilmaz, Y. Baran and N. Özdemir
Comment
Piperazine-based research has attracted considerable attention in recent years. A broad range of compounds displaying
antibacterial (Foroumadi et al., 2007), antifungal (Upadhayaya et al., 2004), anticancer (Chen et al., 2006), antiparasitic
(Cunico et al., 2009), antihistamin (Smits et al., 2008), psychotolytic (Penjišević et al., 2007), and antidepressive activities
(Becker et al., 2006) have been found to contain this versatile core. In view of these important properties, we have undertaken
the X-ray diffraction study of the title compound.
The structure of the title compound is shown in Fig. 1. The structure contains one central piperazine ring (N1/C4/C4i/
N1i/C4ii/C4iii) with two propanol moieties substituted at the two N atoms of the piperazine ring. The centre of the ring
located at a site of 2/m symmetry. The N, O and methyl C atoms are located on the mirror plane, while atoms C2 and C3
show symmetry-imposed disorder.
The interatomic distances and angles in the compound show no anomalies. The piperazine ring adopts a chair conform-
ation, as is evident from the puckering parameters (Cremer & Pople, 1975): QT = 1.0333 (10) Å, q2 = 0.8812 (9) Å, q3 =
0.5396 (6) Å, θ = 58.52 (2)° and φ2 = 30.00 (5)° for the atom sequence N1/C4/C4i/N1i/C4ii/C4iii. Atoms N1 and N1i are on
opposite sides of the C4/C4i/C4ii/C4iii plane and are both displaced from it by 0.2424 (30) Å.
The molecular structure of the title compound contains two intramolecular O—H···N contacts, which form a five-
membered ring with graph-set descriptor S(5) (Bernstein et al., 1995). No intermolecular hydrogen bonds are observed in
the crystal structure. Van der Waals forces stabilize the packing.
Experimental
Piperazine (1.50 g, 17.40 mmol) was dissolved in 50 ml argon saturated methanol. Methanol solution of 2.88 g (50.00 mmol)
propylene oxide was added to the piperazine solution at room temperature. The solution was left under magnetic stirrer for
24 h. The solution volume was reduced by rotary evaporator and the oily product was left for crystallization.
Refinement
H atoms were positioned geometrically and treated using a riding model, fixing the bond lengths at 0.82, 0.93, 0.97 and 0.96
Å for OH, CH, CH2 and CH3 groups, respectively. The isotropic displacement parameters of the H atoms were constrained
at 1.2 Ueq of their parent atom (1.5 Ueq for methyl and OH groups). Atoms C2 and C3 showed symmetry-imposed disorder
and were refined anisotropically using ADP restraints (SIMU and DELU) and half occupancy.supplementary materials
sup-2
Figures
Fig. 1. ORTEP-3 drawing of the title compound, showing 30% probability displacement el-
lipsoids and the atomic numbering scheme. For the sake of clarity, H atoms have been omit-
ted. One of the disorder components is drawn with dashed bonds. [Symmetry codes: (i) 1 - x,
y, 1 - z; (ii) 1 - x, 1 - y, 1 - z; (iii) x, 1 - y, z.]
1,1'-(Piperazine-1,4-diyl)dipropan-2-ol
Crystal data
C10H22N2O2 F(000) = 224
Mr = 202.30 Dx = 1.133 Mg m−3
Monoclinic, C2/m Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -C 2y Cell parameters from 3092 reflections
a = 13.838 (10) Å θ = 3.0–30.0°
b = 7.791 (5) Å µ = 0.08 mm−1
c = 5.543 (4) Å T = 273 K
β = 97.26 (3)° Prism, colourless




diffractometer 441 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tube Rint = 0.139
graphite θmax = 25.5°, θmin = 3.0°
Detector resolution: 10.00 pixels mm-1 h = −16→16
ω scans k = −9→9
2493 measured reflections l = −5→6
604 independent reflections
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.052
Hydrogen site location: inferred from neighbouring
sites
wR(F2) = 0.119 H-atom parameters constrained
S = 1.05
w = 1/[σ2(Fo
2) + (0.0375P)2 + 0.2898P]
where P = (Fo
2 + 2Fc
2)/3
604 reflections (Δ/σ)max < 0.001
46 parameters Δρmax = 0.28 e Å−3
14 restraints Δρmin = −0.34 e Å−3supplementary materials
sup-3
Special details
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq Occ. (<1)
O1 0.78313 (12) 0.5000 0.4674 (3) 0.0706 (7)
H1 0.7297 0.5197 0.3907 0.106* 0.50
N1 0.60084 (15) 0.5000 0.5912 (4) 0.0715 (7)
C1 0.86326 (18) 0.5000 0.8733 (5) 0.0754 (9)
H1A 0.9169 0.4390 0.8197 0.113* 0.50
H1B 0.8573 0.4690 1.0384 0.113* 0.50
H1C 0.8746 0.6213 0.8640 0.113* 0.50
C2 0.7712 (2) 0.4545 (5) 0.7137 (5) 0.0603 (12) 0.50
H2 0.7597 0.3307 0.7233 0.072* 0.50
C3 0.6841 (2) 0.5495 (5) 0.7803 (6) 0.0609 (11) 0.50
H3A 0.6952 0.6724 0.7782 0.073* 0.50
H3B 0.6705 0.5166 0.9413 0.073* 0.50
C4 0.54111 (14) 0.6506 (3) 0.6021 (3) 0.0751 (7)
H4A 0.5806 0.7526 0.5917 0.090*
H4B 0.5150 0.6533 0.7565 0.090*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
O1 0.0609 (11) 0.0975 (15) 0.0541 (11) 0.000 0.0103 (8) 0.000
N1 0.0463 (11) 0.118 (2) 0.0498 (12) 0.000 0.0031 (9) 0.000
C1 0.0527 (15) 0.103 (2) 0.0677 (17) 0.000 −0.0030 (13) 0.000
C2 0.0519 (15) 0.075 (3) 0.0533 (16) 0.0024 (15) 0.0027 (13) −0.0010 (15)
C3 0.0483 (14) 0.084 (3) 0.0490 (14) 0.0021 (14) 0.0016 (12) −0.0047 (14)
C4 0.0807 (13) 0.0883 (15) 0.0563 (11) −0.0195 (11) 0.0084 (9) −0.0038 (11)
Geometric parameters (Å, °)
O1—C2i 1.440 (4) C1—H1B 0.9600
O1—C2 1.440 (4) C1—H1C 0.9600
O1—H1 0.8200 C2—C3 1.499 (4)
N1—C4i 1.441 (3) C2—H2 0.9800supplementary materials
sup-4
N1—C4 1.441 (3) C3—H3A 0.9700
N1—C3 1.507 (3) C3—H3B 0.9700
N1—C3i 1.507 (3) C4—C4ii 1.500 (4)
C1—C2 1.499 (4) C4—H4A 0.9700
C1—C2i 1.499 (4) C4—H4B 0.9700
C1—H1A 0.9600
C2i—O1—H1 103.9 O1—C2—C3 107.7 (2)
C2—O1—H1 109.5 C1—C2—C3 112.8 (3)
C4i—N1—C4 109.0 (2) O1—C2—H2 109.4
C4i—N1—C3 124.8 (2) C1—C2—H2 109.4
C4—N1—C3 98.90 (17) C3—C2—H2 109.4
C4i—N1—C3i 98.90 (17) C2—C3—N1 105.7 (2)
C4—N1—C3i 124.8 (2) C2—C3—H3A 110.6
C2—C1—H1A 109.5 N1—C3—H3A 110.6
C2i—C1—H1A 124.6 C2—C3—H3B 110.6
C2—C1—H1B 109.5 N1—C3—H3B 110.6
C2i—C1—H1B 116.9 H3A—C3—H3B 108.7
H1A—C1—H1B 109.5 N1—C4—C4ii 110.64 (15)
C2—C1—H1C 109.5 N1—C4—H4A 109.5
C2i—C1—H1C 82.4 C4ii—C4—H4A 109.5
H1A—C1—H1C 109.5 N1—C4—H4B 109.5
H1B—C1—H1C 109.5 C4ii—C4—H4B 109.5
O1—C2—C1 108.1 (2) H4A—C4—H4B 108.1
C2i—O1—C2—C1 −70.1 (2) C4i—N1—C3—C2 85.4 (3)
C2i—O1—C2—C3 52.0 (2) C4—N1—C3—C2 −153.8 (2)
C2i—C1—C2—O1 69.7 (2) C3i—N1—C3—C2 52.8 (3)
C2i—C1—C2—C3 −49.2 (3) C4i—N1—C4—C4ii −58.1 (3)
O1—C2—C3—N1 56.3 (3) C3—N1—C4—C4ii 170.2 (2)
C1—C2—C3—N1 175.4 (2) C3i—N1—C4—C4ii −174.2 (2)
Symmetry codes: (i) x, −y+1, z; (ii) −x+1, y, −z+1.
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
O1—H1···N1 0.82 2.22 2.696 (3) 117supplementary materials
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Fig. 1